Quantitative study of the effects of Ketanserin in patients with primary Raynaud's phenomenon. A randomized, double blind, placebo controlled investigation and an additional long term open trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples